FDA Releases Guidance for Preclinical Assessment of Cellular and Gene Therapy Products

Summary

The Food and Drug Administration (FDA) has made available a document outlining recommendations for preclinical studies of investigational cellular and gene therapy products, which will support clinical trials for these products, and clarifies expectations for preclinical information needed to support IND and BLA applications.